FindTrial
Sign In

Application value of wearable patch ultrasound in early monitoring of deep venous thrombosis of lower limbs after hip and knee replacement

Application value of wearable patch ultrasound in early monitoring of deep venous thrombosis of lower limbs after hip and knee replacement

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108757
Enrollment
Unknown
Registered
2025-09-04
Start date
2025-08-13
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep venous thrombosis of the lower extremities

Interventions

Test group:Patch ultrasound examination of deep veins of lower limbs after operation
control group:Routine ultrasound examination of postoperative deep veins of lower limbs

Sponsors

The First Affiliated Hospital of the Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to orthopedic ward undergoing hip or knee arthroplasty. 2. Age ranging from 18 to 80 years. 3. No deep venous thrombosis of lower limbs diagnosed by ultrasound one day before surgery 4. All patients have been informed about the study and have signed the consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with preoperative ultrasound diagnosis of deep vein thrombosis (DVT) of the lower limbs or a history of chronic DVT. 2. Individuals with lower limb varicose veins, venous insufficiency of the deep venous valve, venous aneurysms, lower limb arteriovenous injury, or congenital anomalies. 3. Those with liver dysfunction, heart failure, or lower limb venous hypertension caused by pelvic or abdominal tumors. 4. Individuals with abnormal coagulation function or undergoing long-term anticoagulant therapy. 5. Pregnant or lactating women. 6. Patients with unclear consciousness or inability to cooperate with lower limb vascular ultrasound examination. 7. Participants who voluntarily withdraw from the study during the research period.

Design outcomes

Primary

MeasureTime frame
Popliteal vein diameter;Popliteal vein peak flow velocity;Popliteal vein mean flow velocity;Popliteal vein blood flow volume;Posterior tibial vein diameter;Posterior tibial venous peak flow rate;posterior tibial vein mean flow velocity;posterior tibial vein blood flow volume;Femoral vein diameter;Femoral vein peak flow velocity;Femoral vein mean flow velocity;Femoral vein blood flow volume;Muscle vein diameter;muscle vein peak velocity;muscle vein average velocity;muscle vein blood flow;—

Secondary

MeasureTime frame
D-dimer;Cohagulation Function;C-reactive protein;Neutrophil Ratio;triglyceride;platelet count;blood type;—

Countries

China

Contacts

Public ContactLiwen Liu

First Affiliated Hospital of Air Force Medical University

liuliwen@fmmu.edu.cn+86 135 7197 5528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026